Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 3 , Pages 207-215 , May 2006

HYTAD1-p20: A new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer

  • Antonio Rosato, M.D.

      Affiliations

    • Department of Oncology and Surgical Sciences, Oncology Section, University of Padova, Padova, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-49-8215800/8215858; fax: +39-49-8072854.
    • ,
  • Alessandra Banzato, M.S.

      Affiliations

    • Department of Oncology and Surgical Sciences, Oncology Section, University of Padova, Padova, Italy
    • ,
  • Gilda De Luca, M.S.

      Affiliations

    • Fidia Farmaceutici, Abano Terme, Italy
    • ,
  • Davide Renier, M.S.

      Affiliations

    • Fidia Farmaceutici, Abano Terme, Italy
    • ,
  • Fabio Bettella, Bc.Sc.

      Affiliations

    • Fidia Farmaceutici, Abano Terme, Italy
    • ,
  • Claudio Pagano, M.D.

      Affiliations

    • Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
    • ,
  • Giovanni Esposito, M.D.

      Affiliations

    • Department of Oncology and Surgical Sciences, Oncology Section, University of Padova, Padova, Italy
    • ,
  • Paola Zanovello, M.S.

      Affiliations

    • Department of Oncology and Surgical Sciences, Oncology Section, University of Padova, Padova, Italy
    • ,
  • PierFrancesco Bassi, M.D.

      Affiliations

    • Department of Oncology and Surgical Sciences, Urology Section, University of Padova, Padova, Italy

Received 9 May 2005 ,Revised 3 August 2005 ,Accepted 4 August 2005.

References 

  1. Borden LS , Clark PE , Hall MC . Bladder cancer . Curr Opin Oncol . 2004;16:257–262
  2. Dinney CP , McConkey DJ , Millikan RE , et al.   Focus on bladder cancer . Cancer Cell . 2004;6:111–116
  3. Schenkman E , Lamm DL . Superficial bladder cancer therapy . Scientific WorldJournal . 2004;4(Suppl 1):387–399
  4. Kassouf W , Kamat AM . Current state of immunotherapy for bladder cancer . Expert Rev Anticancer Ther . 2004;4:1037–1046
  5. Crawford ED . Intravesical therapy for superficial cancer (Need for more options) . J Clin Oncol . 2002;20:3185–3186
  6. Jordan MA , Wilson L . Microtubules as a target for anticancer drugs . Nat Rev Cancer . 2004;4:253–265
  7. Cormio G , Di Vagno G , Melilli GA , et al.   Hypersensitivity reactions in ovarian cancer patients receiving paclitaxel . J Chemother . 1999;11:407–409
  8. Weiss RB , Donehower RC , Wiernik PH , et al.   Hypersensitivity reactions from taxol . J Clin Oncol . 1990;8:1263–1268
  9. Nativ O , Aronson M , Medalia O , et al.   Anti-neoplastic activity of paclitaxel on experimental superficial bladder cancer (In vivo and in vitro studies) . Int J Cancer . 1997;70:297–301
  10. Knemeyer I , Wientjes MG , Au JL . Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment . Cancer Chemother Pharmacol . 1999;44:241–248
  11. Toole BP . Hyaluronan (From extracellular glue to pericellular cue) . Nat Rev Cancer . 2004;4:528–539
  12. Marhaba R , Zoller M . CD44 in cancer progression (Adhesion, migration and growth regulation) . J Mol Histol . 2004;35:211–231
  13. Nedvetzki S , Gonen E , Assayag N , et al.   RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice (A different interpretation of redundancy) . Proc Natl Acad Sci U S A . 2004;101:18081–18086
  14. Weigel JA , Raymond RC , McGary C , et al.   A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver . J Biol Chem . 2003;278:9808–9812
  15. Kong QY , Liu J , Chen XY , et al.   Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder . Oncol Rep . 2003;10:51–55
  16. Lipponen P , Aaltoma S , Kosma VM , et al.   Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up . J Pathol . 1998;186:157–164
  17. Ross JS , del Rosario AD , Bui HX , et al.   Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma . Mod Pathol . 1996;9:854–860
  18. Luo Y , Bernshaw NJ , Lu ZR , et al.   Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates . Pharm Res . 2002;19:396–402
  19. Luo Y , Ziebell MR , Prestwich GD . A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells . Biomacromolecules . 2000;1:208–218
  20. Luo Y , Prestwich GD . Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate . Bioconjug Chem . 1999;10:755–763
  21. Li H , Liu Y , Shu XZ , et al.   Synthesis and biological evaluation of a cross-linked hyaluronan-mitomycin C hydrogel . Biomacromolecules . 2004;5:895–902
  22. Quintieri L , Rosato A , Napoli E , et al.   In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin (Role of cytochrome P450 3A) . Cancer Res . 2000;60:3232–3238
  23. UKCCCR guidelines for the welfare of animals in experimental neoplasia . Cancer Metastasis Rev . 1989;8:82–88
  24. Lu Z , Yeh TK , Tsai M , et al.   Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy . Clin Cancer Res . 2004;10:7677–7684
  25. Au JL , Kalns J , Gan Y , et al.   Pharmacologic effects of paclitaxel in human bladder tumors . Cancer Chemother Pharmacol . 1997;41:69–74
  26. Suh H , Jeong B , Rathi R , et al.   Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres . J Biomed Mater Res . 1998;42:331–338
  27. Wang YM , Sato H , Adachi I , et al.   Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol . Chem Pharm Bull (Tokyo) . 1996;44:1935–1940
  28. Harper E , Dang W , Lapidus RG , et al.   Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice . Clin Cancer Res . 1999;5:4242–4248
  29. Le Visage C , Rioux-Leclercq N , Haller M , et al.   Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer . J Urol . 2004;171:1324–1329
  30. Sandri G , Rossi S , Ferrari F , et al.   Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum . J Pharm Pharmacol . 2004;56:1083–1090

☆ This work was supported by a grant from Fidia Farmaceutici spa. Antonio Rosato and Alessandra Banzato contributed equally to this work.

PII: S1078-1439(05)00219-X

doi: 10.1016/j.urolonc.2005.08.020

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 3 , Pages 207-215 , May 2006

Article Tools

* Image Usage & Resolution